BTX
$0.51
Brooklyn Immunotherapeutics
($.02)
(3.56%)
BTX
Earnings Whisper ®
N/A
2nd Quarter June 2022
Consensus:  $0.00
Revenue:  N/A
Friday
Sep 30
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when BTX reports earnings?
Beat
Meet
Miss

Where is BTX's stock price going from here?
Up
Flat
Down
Stock chart of BTX
Analysts
Summary of analysts' recommendations for BTX
Score
Grade
Pivots
Resistance
$0.61
$0.59
$0.56

$0.54

Support
$0.51
$0.49
$0.46
Tweet
Growth
Description
Brooklyn ImmunoTherapeutics LLC. is a late clinical-stage biopharmaceutical company. It is focused on IL-2 cytokine-based therapies in treating patients with cancer. Brooklyn ImmunoTherapeutics LLC., formerly known as NTN Buzztime, is based in CARLSBAD, Calif.